Clincosm LogoSign in Get a demo

Leukemia

Showing 51 - 75 of 1,510
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Leukemia Trial (Prehabilitation)

Not yet recruiting
  • Leukemia
  • Prehabilitation
  • (no location specified)
Dec 5, 2022

Leukemia, Lymphoma Trial in Houston (Ofatumumab)

Active, not recruiting
  • Leukemia
  • Lymphoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Dec 9, 2022

Leukemia, Myelodysplastic Syndrome, Non-Hodgkins Lymphoma Trial in New York (fludarabine, cyclophosphamide, thiotepa, radiation

Completed
Has Results
  • Leukemia
  • +4 more
  • fludarabine, cyclophosphamide, thiotepa, radiation therapy, unrelated donor umbilical cord blood graft
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Nov 10, 2022

Cancer, Cancer Metastatic, Tumors Trial in Los Angeles (Virtual group based physical activity (BurnAlong) and Social Media

Recruiting
  • Cancer
  • +21 more
  • Virtual group based physical activity (BurnAlong) and Social Media Discussion Board
  • Los Angeles, California
    Cedars-Sinai Medical Center
Dec 7, 2022

Leukemia, Stem Cell Transplantation Trial in Munich (FBTA05)

Withdrawn
  • Leukemia
  • Stem Cell Transplantation
  • Munich, Bavaria, Germany
    3. Medizinische Klinik, Klinikum rechts der Isar der TU München
Dec 5, 2022

Leukemia Trial in Worldwide (Dasatinib)

Active, not recruiting
Has Results
  • Leukemia
  • Birmingham, Alabama
  • +173 more
Dec 1, 2022

A Single-Site Tissue Repository Providing Annotated Biospecimens

Recruiting
  • Age-Related Macular Degeneration
  • +46 more
  • Specimen sample
  • Waltham, Massachusetts
    Sanguine Biosciences
Nov 22, 2022

Selection of Allogeneic Hematopoietic Cell Donors Based on KIR

Active, not recruiting
  • Leukemia
  • KIR genotyping
  • HLA genotyping
  • Tampa, Florida
  • +9 more
Nov 29, 2022

Lymphoma, Leukemia Trial in United States (CPI-613)

Recruiting
  • Lymphoma
  • Leukemia
  • Duarte, California
  • +9 more
Nov 28, 2022

Chronic Myelomonocytic Leukemia, Leukemia Trial in United States (Ruxolitinib)

Active, not recruiting
  • Chronic Myelomonocytic Leukemia
  • Leukemia
  • Tampa, Florida
  • +4 more
Nov 11, 2022

Validation for Early Cancer Detection and Minimal Residual

Recruiting
  • Brain Cancer
  • +19 more
    • Duarte, California
    • +6 more
    Nov 10, 2022

    Acute Myeloid Leukemia, Accelerated Phase Chronic Myeloid Leukemia, Blast Phase Chronic Myeloid Leukemia Trial in Worldwide

    Recruiting
    • Acute Myeloid Leukemia
    • +8 more
    • Ghent, Belgium
    • +28 more
    Nov 11, 2022

    Drug/Agent Toxicity by Tissue/Organ, Leukemia Trial in Canada, Puerto Rico, United States (asparaginase, cyclophosphamide,

    Completed
    Has Results
    • Drug/Agent Toxicity by Tissue/Organ
    • Leukemia
    • Boston, Massachusetts
    • +9 more
    Nov 9, 2022

    Leukemia, Lymphoma Trial in Memphis (radiation, drug, biological, device)

    Completed
    Has Results
    • Leukemia
    • Lymphoma
    • Total Lymphoid Irradiation
    • +10 more
    • Memphis, Tennessee
      St. Jude Children's Research Hospital
    Oct 28, 2022

    Chronic Lymphocytic Leukemia, Leukemia Trial in United States (Ibrutinib, Fludarabine, Cyclophosphamide)

    Active, not recruiting
    Has Results
    • Chronic Lymphocytic Leukemia
    • Leukemia
    • Coral Gables, Florida
    • +8 more
    Sep 28, 2022

    Leukemia, Lymphoma Trial in Houston (Rituximab, Lenalidomide)

    Active, not recruiting
    • Leukemia
    • Lymphoma
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Oct 11, 2022

    Leukemia Trial in Austria, Germany, Italy (arsenic trioxide, idarubicin, mercaptopurine)

    Completed
    • Leukemia
    • arsenic trioxide
    • +5 more
    • Innsbruck, Austria
    • +109 more
    Oct 10, 2022

    Lymphoma, Leukemia, Plasma Cell Dyscrasia Trial in San Francisco (Web Application)

    Not yet recruiting
    • Lymphoma
    • +2 more
    • Web Application
    • San Francisco, California
      University of California, San Francisco
    Oct 4, 2022

    Leukemia Trial in Boston, Houston (Venetoclax, Standard Chemotherapy)

    Recruiting
    • Leukemia
    • Chicago, Illinois
    • +2 more
    Oct 3, 2022

    Chronic Myeloproliferative Disorders, GVHD, Leukemia Trial in Buffalo (sargramostim)

    Completed
    • Chronic Myeloproliferative Disorders
    • +5 more
    • sargramostim
    • Buffalo, New York
      Roswell Park Cancer Institute
    Oct 3, 2022

    Leukemia Trial in Houston (Brentuximab Vedotin, 5-Azacytidine)

    Terminated
    Has Results
    • Leukemia
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Sep 7, 2022

    Leukemia, Acute Myeloid Leukemia, AML Trial in Tampa (Selinexor, Daunorubicin, Cytarabine)

    Completed
    • Leukemia
    • +2 more
    • Tampa, Florida
      H. Lee Moffitt Cancer Center and Research Institute
    Sep 30, 2022

    Leukemia Trial in Cincinnati (Vyxeos, Venetoclax)

    Suspended
    • Leukemia
    • Cincinnati, Ohio
      Cincinnati Children's Hospital Medical Center
    Sep 21, 2022

    Pediatric Cancer, Hodgkin Disease, CD30-Positive DLBCL Trial in Milwaukee (anti-CD30 Bispecific Antibody-armed

    Not yet recruiting
    • Pediatric Cancer
    • +11 more
    • anti-CD30 Bispecific Antibody-armed anti-CD3-Activated Autologous T-cells (CD30 biAb-AATC)
    • Milwaukee, Wisconsin
      Children's Wisconsin
    Sep 14, 2022

    Glioblastomas, Sarcoma, Astrocytoma Trial run by the NCI (Enhanced Mindfulness Intervention, Psychoeducation)

    Completed
    • Glioblastomas
    • +4 more
    • Enhanced Mindfulness Intervention
    • Psychoeducation
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Sep 14, 2022